Skip to content
10-K

Annual Report

Bio Essence Corp BIOE

0001213900-26-035467

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 38.01M sh
Shares Diluted FY 2025 · Dec 31, 2025 38.01M sh
Shares Diluted FY 2025 · Dec 31, 2024 38.01M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.57M
Operating Cash Flow FY 2025 · Dec 31, 2024 $623.87K
Long Term Debt FY 2025 · Dec 31, 2025 $57.48K
Stockholders Equity FY 2025 · Dec 31, 2025 −$2.07M
Stockholders Equity FY 2025 · Dec 31, 2024 −$2.97M
Stockholders Equity FY 2025 · Dec 31, 2023 −$1.66M
Current Liabilities FY 2025 · Dec 31, 2025 $2.44M
Current Liabilities FY 2025 · Dec 31, 2024 $2.8M
Total Liabilities FY 2025 · Dec 31, 2025 $2.5M
Total Liabilities FY 2025 · Dec 31, 2024 $3.25M
Current Assets FY 2025 · Dec 31, 2025 $422.38K
Current Assets FY 2025 · Dec 31, 2024 $280.69K
Total Assets FY 2025 · Dec 31, 2025 $422.47K
Total Assets FY 2025 · Dec 31, 2024 $281.02K
Sga Expense FY 2025 · Dec 31, 2025 $497.81K
Sga Expense FY 2025 · Dec 31, 2024 $676.52K
Net Income FY 2025 · Dec 31, 2025 $896.2K
Net Income FY 2025 · Dec 31, 2024 −$1.31M
Operating Income FY 2025 · Dec 31, 2025 $900.01K
Operating Income FY 2025 · Dec 31, 2024 −$459.44K
Gross Profit FY 2025 · Dec 31, 2025 $1.43M
Gross Profit FY 2025 · Dec 31, 2024 $217.08K
Cost Of Revenue FY 2025 · Dec 31, 2025 $469.15K
Cost Of Revenue FY 2025 · Dec 31, 2024 $106.86K
Revenue FY 2025 · Dec 31, 2025 $1.9M
Revenue FY 2025 · Dec 31, 2024 $323.94K